Treatment options for parasomnias

Neurologic Clinics

Volumn 28, Issue 4, 2010, Pages 1089-1106

  Attarian, Hrayr ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Anticholinergics; Anticonvulsants; Antidepressants; Benzodiazepines; Cognitive behavioral treatment; Prazosin

Indexed keywords

5 HYDROXYTRYPTOPHAN; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; DONEPEZIL; FEMOXETINE; FLUNARIZINE; FLUOXETINE; FLURAZEPAM; FLUVOXAMINE; GABAPENTIN; IMIPRAMINE; LEVODOPA; MELATONIN; NEFAZODONE; NIFEDIPINE; OLANZAPINE; PAROXETINE; PRAMIPEXOLE; PRAZOSIN; PROTRIPTYLINE; RIVASTIGMINE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERAPAMIL; VILOXAZINE;

AROUSAL; BEDTIME DOSAGE; CARDIOTOXICITY; CATATHRENIA; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; CONFUSION; DISEASE ASSOCIATION; DISSOCIATIVE DISORDER; EATING DISORDER; ENURESIS; EXPLODING HEAD SYNDROME; HALLUCINATION; HUMAN; NIGHTMARE; PARASOMNIA; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REM SLEEP; REVIEW; SLEEP DISORDER; SLEEP TERROR; SLEEP WALKING;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; COGNITIVE THERAPY; HUMANS; PARASOMNIAS; SEROTONIN UPTAKE INHIBITORS;

EID: 77956244743     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2010.03.025     Document Type: Review

References (160)

1. Kotagal S. Parasomnias in childhood. Sleep Med Rev 2009, 13(2):157-168.
2. Plazzi G., Vetrugno R., Provini F., et al. Sleepwalking and other ambulatory behaviours during sleep. Neurol Sci 2005, 26(Suppl 3):s193-s198.
3. Nguyen B.H., Perusse D., Paquet J., et al. Sleep terrors in children: a prospective study of twins. Pediatrics 2008, 122(6):e1164-e1167.
4. Schenck C.H., Mahowald M.W. Rapid eye movement sleep parasomnias. Neurol Clin 2005, 23(4):1107-1126.
5. Cheyne J.A. Sleep paralysis episode frequency and number, types, and structure of associated hallucinations. J Sleep Res 2005, 14(3):319-324.
6. Lancee J., Spoormaker V.I., Krakow B., et al. A systematic review of cognitive-behavioral treatment for nightmares: toward a well-established treatment. J Clin Sleep Med 2008, 4(5):475-480.
7. Turkus J.A., Kahler J.A. Therapeutic interventions in the treatment of dissociative disorders. Psychiatr Clin North Am 2006, 29(1):245-262. xi.
8. Robson W.L. Clinical practice. Evaluation and management of enuresis. N Engl J Med 2009, 360(14):1429-1436.
9. Vetrugno R., Provini F., Plazzi G., et al. Catathrenia (nocturnal groaning): a new type of parasomnia. Neurology 2001, 56(5):681-683.
10. Pearce J.M. Clinical features of the exploding head syndrome. J Neurol Neurosurg Psychiatry 1989, 52(7):907-910.
11. Silber M.H., Hansen M.R., Girish M. Complex nocturnal visual hallucinations. Sleep Med 2005, 6(4):363-366.
12. Schenck C.H., Mahowald M.W. Review of nocturnal sleep-related eating disorders. Int J Eat Disord 1994, 15(4):343-356.
13. AASM International classification of sleep disorders: diagnostic and coding manual 2005, American Academy of Sleep Medicine, Westchester (IL). 2nd edition.
14. Mason T.B., Pack A.I. Pediatric parasomnias. Sleep 2007, 30(2):141-151.
15. Guilleminault C., Palombini L., Pelayo R., et al. Sleepwalking and sleep terrors in prepubertal children: what triggers them?. Pediatrics 2003, 111(1):e17-e25.
16. Pressman M.R. Disorders of arousal from sleep and violent behavior: the role of physical contact and proximity. Sleep 2007, 30(8):1039-1047.
17. Mahowald M.W., Schenck C.H. Non-rapid eye movement sleep parasomnias. Neurol Clin 2005, 23(4):1077-1106. vii.
18. Ohayon M.M., Guilleminault C., Priest R.G. Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders. J Clin Psychiatry 1999, 60(4):268-276. [quiz: 277].
19. Harris M., Grunstein R.R. Treatments for somnambulism in adults: assessing the evidence. Sleep Med Rev 2008, 13(4):295-297.
20. Tobin J. Treatment of somnambulism with anticipatory awakening. J Pediatr 1991, 122(3):426-427.
21. Johnson M., Lerner M. Amelioration of infant sleep disturbances: effects of scheduled awakenings by compliant parents. Infant Ment Health J 1985, 6:21-30.
22. Remulla A., Guilleminault C. Somnambulism (sleepwalking). Expert Opin Pharmacother 2004, 5(10):2069-2074.
23. Reid W.H., Ahmed I., Levie C.A. Treatment of sleepwalking: a controlled study. Am J Psychother 1981, 35(1):27-37.
24. Reid W.H., Haffke E.A., Chu C.C. Diazepam in intractable sleepwalking: a pilot study. Hillside J Clin Psychiatry 1984, 6(1):49-55.
25. Schenck C.H., Mahowald M.W. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 1996, 100(3):333-337.
26. Schenck C.H., Milner D.M., Hurwitz T.D., et al. A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry 1989, 146(9):1166-1173.
27. Berlin R.M., Qayyum U. Sleepwalking: diagnosis and treatment through the life cycle. Psychosomatics 1986, 27(11):755-760.
28. Kavey N.B., Whyte J., Resor S.R., et al. Somnambulism in adults. Neurology 1990, 40(5):749-752.
29. Cooper A.J. Treatment of coexistent night-terrors and somnambulism in adults with imipramine and diazepam. J Clin Psychiatry 1987, 48(5):209-210.
30. Stores G. Aspects of parasomnias in childhood and adolescence. Arch Dis Child 2009, 94(1):63-69.
31. Lillywhite A.R., Wilson S.J., Nutt D.J. Successful treatment of night terrors and somnambulism with paroxetine. Br J Psychiatry 1994, 164(4):551-554.
32. Crisp A.H. The sleepwalking/night terrors syndrome in adults. Postgrad Med J 1996, 72(852):599-604.
33. Jan J.E., Freeman R.D., Wasdell M.B., et al. A child with severe night terrors and sleep-walking responds to melatonin therapy. Dev Med Child Neurol 2004, 46(11):789.
34. Stores G. Clinical diagnosis and misdiagnosis of sleep disorders. J Neurol Neurosurg Psychiatry 2007, 78(12):1293-1297.
35. Heussler H.S. 9. Common causes of sleep disruption and daytime sleepiness: childhood sleep disorders II. Med J Aust 2005, 182(9):484-489.
36. Kales J.C., Cadieux R.J., Soldatos C.R., et al. Psychotherapy with night-terror patients. Am J Psychother 1982, 36(3):399-407.
37. Kellerman J. Behavioral treatment of night terrors in a child with acute leukemia. J Nerv Ment Dis 1979, 167(3):182-185.
38. Hurwitz T.D., Mahowald M.W., Schenck C.H., et al. A retrospective outcome study and review of hypnosis as treatment of adults with sleepwalking and sleep terror. J Nerv Ment Dis 1991, 179(4):228-233.
39. Allen R.M. Attenuation of drug-induced anxiety dreams and pavor nocturnus by benzodiazepines. J Clin Psychiatry 1983, 44(3):106-108.
40. Burstein A., Burstein A. Treatment of night terrors with imipramine. J Clin Psychiatry 1983, 44(2):82.
41. Touchon J. Encephale 1995, 21(Spec No 7):41-47. [in French].
42. Mahowald M.W., Schenck C.H. Diagnosis and management of parasomnias. Clin Cornerstone 2000, 2(5):48-57.
43. Jan J.E., Freeman R.D. Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade?. Dev Med Child Neurol 2004, 46(11):776-782.
44. Bruni O., Ferri R., Miano S., et al. l-5-Hydroxytryptophan treatment of sleep terrors in children. Eur J Pediatr 2004, 163(7):402-407.
45. Iranzo A., Santamaria J. Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder. Sleep 2005, 28(2):203-206.
46. Henriques-Filho P.S., Pratesi R. Sleep apnea and REM sleep behavior disorder in patients with Chiari malformations. Arq Neuropsiquiatr 2008, 66(2B):344-349.
47. Winkelman J.W., James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004, 27(2):317-321.
48. Schenck C.H., Mahowald M.W., Kim S.W., et al. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992, 15(3):226-235.
49. Gagnon J.F., Postuma R.B., Mazza S., et al. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 2006, 5(5):424-432.
50. Olson E.J., Boeve B.F., Silber M.H. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000, 123(Pt 2):331-339.
51. Schenck C.H., Hurwitz T.D., Mahowald M.W. Symposium: normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. J Sleep Res 1993, 2(4):224-231.
52. Lapierre O., Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 1992, 42(7):1371-1374.
53. Kunz D., Bes F. Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations. Neuropsychobiology 1997, 36(4):211-214.
54. Kunz D., Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord 1999, 14(3):507-511.
55. Takeuchi N., Uchimura N., Hashizume Y., et al. Melatonin therapy for REM sleep behavior disorder. Psychiatry Clin Neurosci 2001, 55(3):267-269.
56. Boeve B.F., Silber M.H., Ferman T.J. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003, 4(4):281-284.
57. Limousin N., Dehais C., Gout O., et al. A brainstem inflammatory lesion causing REM sleep behavior disorder and sleepwalking (parasomnia overlap disorder). Sleep Med 2009, 10(9):1059-1062.
58. Gagnon J.F., Postuma R.B., Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology 2006, 67(5):742-747.
59. Ringman J.M., Simmons J.H. Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 2000, 55(6):870-871.
60. Massironi G., Galluzzi S., Frisoni G.B. Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies. Int Psychogeriatr 2003, 15(4):377-383.
61. Grace J.B., Walker M.P., McKeith I.G. A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2000, 15(11):1028-1033.
62. Maclean L.E., Collins C.C., Byrne E.J. Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep. Int Psychogeriatr 2001, 13(3):277-288.
63. Fantini M.L., Gagnon J.F., Filipini D., et al. The effects of pramipexole in REM sleep behavior disorder. Neurology 2003, 61(10):1418-1420.
64. Kumru H., Iranzo A., Carrasco E., et al. Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease. Sleep 2008, 31(10):1418-1421.
65. Takahashi T., Mitsuya H., Murata T., et al. Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder. Sleep Med 2008, 9(3):317-319.
66. Gangdev P. Comments on sleep paralysis. Transcult Psychiatry 2006, 43(4):692-694.
67. Gangdev P. Relevance of sleep paralysis and hypnic hallucinations to psychiatry. Australas Psychiatry 2004, 12(1):77-80.
68. Chen C.N. The use of clomipramine as an REM sleep suppressant in narcolepsy. Postgrad Med J 1980, 56(Suppl 1):86-89.
69. Bassetti C. Narcolepsy. Curr Treat Options Neurol 1999, 1(4):291-298.
70. Mitler M.M., Hajdukovic R., Erman M., et al. Narcolepsy. J Clin Neurophysiol 1990, 7(1):93-118.
71. Snyder S., Hams G. Serotoninergic agents in the treatment of isolated sleep paralysis. Am J Psychiatry 1982, 139(9):1202-1203.
72. Sandyk R. Resolution of sleep paralysis by weak electromagnetic fields in a patient with multiple sclerosis. Int J Neurosci 1997, 90(3-4):145-157.
73. Krakow B., Johnston L., Melendrez D., et al. An open-label trial of evidence-based cognitive behavior therapy for nightmares and insomnia in crime victims with PTSD. Am J Psychiatry 2001, 158(12):2043-2047.
74. Krakow B., Hollifield M., Johnston L., et al. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA 2001, 286(5):537-545.
75. Spoormaker V.I., van den Bout J. Lucid dreaming treatment for nightmares: a pilot study. Psychother Psychosom 2006, 75(6):389-394.
76. Grandi S., Fabbri S., Panattoni N., et al. Self-exposure treatment of recurrent nightmares: waiting-list-controlled trial and 4-year follow-up. Psychother Psychosom 2006, 75(6):384-388.
77. Ng B.Y., Lee T.S. Hypnotherapy for sleep disorders. Ann Acad Med Singapore 2008, 37(8):683-688.
78. Krakow B.J., Melendrez D.C., Johnston L.G., et al. Sleep dynamic therapy for Cerro Grande Fire evacuees with posttraumatic stress symptoms: a preliminary report. J Clin Psychiatry 2002, 63(8):673-684.
79. Tanner B.A. Multimodal behavioral treatment of nonrepetitive, treatment-resistant nightmares: a case report. Percept Mot Skills 2004, 99(3 Pt 2):1139-1146.
80. Davis J.L., Wright D.C. Randomized clinical trial for treatment of chronic nightmares in trauma-exposed adults. J Trauma Stress 2007, 20(2):123-133.
81. Daly C.M., Doyle M.E., Radkind M., et al. Clinical case series: the use of Prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans. Mil Med 2005, 170(6):513-515.
82. Dierks M.R., Jordan J.K., Sheehan A.H. Prazosin treatment of nightmares related to posttraumatic stress disorder. Ann Pharmacother 2007, 41(6):1013-1017.
83. Miller L.J. Prazosin for the treatment of posttraumatic stress disorder sleep disturbances. Pharmacotherapy 2008, 28(5):656-666.
84. Raskind M.A., Peskind E.R., Hoff D.J., et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry 2007, 61(8):928-934.
85. Taylor F., Raskind M.A. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol 2002, 22(1):82-85.
86. Taylor H.R., Freeman M.K., Cates M.E. Prazosin for treatment of nightmares related to posttraumatic stress disorder. Am J Health Syst Pharm 2008, 65(8):716-722.
87. Cates M.E., Bishop M.H., Davis L.L., et al. Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Ann Pharmacother 2004, 38(9):1395-1399.
88. Gillin J.C., Smith-Vaniz A., Schnierow B., et al. An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. J Clin Psychiatry 2001, 62(10):789-796.
89. Warner M.D., Dorn M.R., Peabody C.A. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry 2001, 34(4):128-131.
90. Hamner M.B., Brodrick P.S., Labbate L.A. Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry 2001, 13(3):141-146.
91. Aalbersberg C.F., Mulder J.M. Tijdschr Psychiatr 2006, 48(6):487-491. [in Dutch].
92. Jakovljevic M., Sagud M., Mihaljevic-Peles A. Olanzapine in the treatment-resistant, combat-related PTSD-a series of case reports. Acta Psychiatr Scand 2003, 107(5):394-396. [discussion: 396].
93. Fraser G.A. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther 2009, 15(1):84-88.
94. Ogden P., Pain C., Fisher J. A sensorimotor approach to the treatment of trauma and dissociation. Psychiatr Clin North Am 2006, 29(1):263-279. xi-xii.
95. Umlauf M.G., Chasens E.R. Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis. Sleep Med Rev 2003, 7(5):403-411.
96. Bower W.F., Sit F.K., Yeung C.K. Nocturnal enuresis in adolescents and adults is associated with childhood elimination symptoms. J Urol 2006, 176(4 Pt 2):1771-1775.
97. Troshin V.M., Radaeva T.M., Khaletskaia O.V., et al. Zh Nevrol Psikhiatr Im S S Korsakova 1994, 94(3):35-39. [in Russian].
98. Baeyens D., Roeyers H., Hoebeke P., et al. The impact of attention deficit hyperactivity disorders on brainstem dysfunction in nocturnal enuresis. J Urol 2006, 176(2):744-748.
99. Rembratt A., Norgaard J.P., Andersson K.E. Nocturia and associated morbidity in a community-dwelling elderly population. BJU Int 2003, 92(7):726-730.
100. Toros F., Erdogan K. Paroxetine-induced enuresis. Eur Psychiatry 2003, 18(1):43-44.
101. Flanagan R.J. Side effects of clozapine and some other psychoactive drugs. Curr Drug Saf 2008, 3(2):115-122.
102. Yokoyama A., Saito Y., Maegaki Y., et al. No To Hattatsu 2007, 39(3):227-228. [in Japanese].
103. Kantrowitz J.T., Srihari V.H., Tek C. Three cases of risperidone-induced enuresis. Schizophr Res 2006, 84(1):174-175.
104. Walter S., Colstrup H., Kristensen J.K. Adult enuresis and hyperthyroidism. Urology 1983, 22(2):151-152.
105. Pinhas-Hamiel O., Modan-Moses D., Herman-Raz M., et al. Obesity in girls and penetrative sexual abuse in childhood. Acta Paediatr 2009, 98(1):144-147.
106. Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics 1997, 100(2 Pt 1):228-232.
107. Neveus T., von Gontard A., Hoebeke P., et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol 2006, 176(1):314-324.
108. Van Hoeck K.J., Bael A., Van Dessel E., et al. Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children. J Urol 2007, 178(5):2132-2136.
109. Glazener C.M., Evans J.H., Peto R.E. Alarm interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 2005, 2. CD002911.
110. Butler R.J., Holland P., Gasson S., et al. Exploring potential mechanisms in alarm treatment for primary nocturnal enuresis. Scand J Urol Nephrol 2007, 41(5):407-413.
111. Bonde H.V., Andersen J.P., Rosenkilde P. Nocturnal enuresis: change of nocturnal voiding pattern during alarm treatment. Scand J Urol Nephrol 1994, 28(4):349-352.
112. El-Bahnasawy M.S., Shaaban H., Gomha M.A., et al. Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study. Scand J Urol Nephrol 2008, 42(4):344-351.
113. Huo J.S. Treatment of 11 cases of chronic enuresis by acupuncture and massage. J Tradit Chin Med 1988, 8(3):195-196.
114. Cardan E. Spinal morphine in enuresis. Br J Anaesth 1985, 57(3):354.
115. Janknegt R.A., Moonen W.A., Schreinemachers L.M. Transection of the bladder as a method of treatment in adult enuresis nocturna. Br J Urol 1979, 51(4):275-277.
116. Schulman S.L., Stokes A., Salzman P.M. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. J Urol 2001, 166(6):2427-2431.
117. Skoog S.J., Stokes A., Turner K.L. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis. J Urol 1997, 158(3 Pt 2):1035-1040.
118. Stenberg A., Lackgren G. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics 1994, 94(6 Pt 1):841-846.
119. Robson W.L., Norgaard J.P., Leung A.K. Hyponatremia in patients with nocturnal enuresis treated with DDAVP. Eur J Pediatr 1996, 155(11):959-962.
120. Robson W.L., Leung A.K., Norgaard J.P. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. J Urol 2007, 178(1):24-30.
121. Cvetkovic R.S., Plosker G.L. Desmopressin: in adults with nocturia. Drugs 2005, 65(1):99-107. [discussion: 108-9].
122. Austin P.F., Ferguson G., Yan Y., et al. Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial. Pediatrics 2008, 122(5):1027-1032.
123. Radvanska E., Kovacs L., Rittig S. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis. J Urol 2006, 176(2):764-768. [discussion: 768-9].
124. Fitzgerald M.P., Lemack G., Wheeler T., et al. Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy. Int Urogynecol J Pelvic Floor Dysfunct 2008, 19(11):1545-1550.
125. Glazener C.M., Evans J.H., Peto R.E. Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev 2003, 3. CD002117.
126. Neveus T. Reboxetine in therapy-resistant enuresis: results and pathogenetic implications. Scand J Urol Nephrol 2006, 40(1):31-34.
127. Bindelglas P.M., Dee G. Enuresis treatment with imipramine hydrochloride: a 10-year follow-up study. Am J Psychiatry 1978, 135(12):1549-1552.
128. Hunsballe J.M., Rittig S., Pedersen E.B., et al. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria. J Urol 1997, 158(3 Pt 1):830-836.
129. Praharaj S.K., Arora M. Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea. Br J Clin Pharmacol 2007, 63(1):128-129.
130. Gillman M.A., Sandy R. Maprotiline in nocturnal enuresis. J Clin Psychiatry 1985, 46(12):546.
131. Iriarte J., Alegre M., Urrestarazu E., et al. Continuous positive airway pressure as treatment for catathrenia (nocturnal groaning). Neurology 2006, 66(4):609-610.
132. Vetrugno R., Lugaresi E., Plazzi G., et al. Catathrenia (nocturnal groaning): an abnormal respiratory pattern during sleep. Eur J Neurol 2007, 14(11):1236-1243.
133. Guilleminault C., Hagen C.C., Khaja A.M. Catathrenia: parasomnia or uncommon feature of sleep disordered breathing?. Sleep 2008, 31(1):132-139.
134. Songu M., Yilmaz H., Yuceturk A.V., et al. Effect of CPAP therapy on catathrenia and OSA: a case report and review of the literature. Sleep Breath 2008, 12(4):401-405.
135. Pevernagie D.A., Boon P.A., Mariman A.N., et al. Vocalization during episodes of prolonged expiration: a parasomnia related to REM sleep. Sleep Med 2001, 2(1):19-30.
136. Green M.W. The exploding head syndrome. Curr Pain Headache Rep 2001, 5(3):279-280.
137. Evans R.W., Pearce J.M. Exploding head syndrome. Headache 2001, 41(6):602-603.
138. Evans R.W. Post-traumatic headaches. Neurol Clin 2004, 22(1):237-249. viii.
139. Sachs C., Svanborg E. The exploding head syndrome: polysomnographic recordings and therapeutic suggestions. Sleep 1991, 14(3):263-266.
140. Jacome D.E. Exploding head syndrome and idiopathic stabbing headache relieved by nifedipine. Cephalalgia 2001, 21(5):617-618.
141. Chakravarty A. Exploding head syndrome: report of two new cases. Cephalalgia 2008, 28(4):399-400.
142. Ohayon M.M., Priest R.G., Caulet M., et al. Hypnagogic and hypnopompic hallucinations: pathological phenomena?. Br J Psychiatry 1996, 169(4):459-467.
143. Mahowald M.W., Woods S.R., Schenck C.H. Sleeping dreams, waking hallucinations, and the central nervous system. Dreaming 1998, 8(2):89-102.
144. Ohayon M.M. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 2000, 97(2-3):153-164.
145. Kavey N.B., Whyte J. Somnambulism associated with hallucinations. Psychosomatics 1993, 34(1):86-90.
146. Manford M., Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998, 121(Pt 10):1819-1840.
147. Takata K., Inoue Y., Hazama H., et al. Night-time hypnopompic visual hallucinations related to REM sleep disorder. Psychiatry Clin Neurosci 1998, 52(2):207-209.
148. Coletti Moja M., Milano E., Gasverde S., et al. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Neurol Sci 2005, 26(3):168-170.
149. Olbrich K., Muhlhans B., Allison K.C., et al. Night eating, binge eating and related features in patients with obstructive sleep apnea syndrome. Eur Eat Disord Rev 2009, 17(2):120-127.
150. Winkelman J.W. Clinical and polysomnographic features of sleep-related eating disorder. J Clin Psychiatry 1998, 59(1):14-19.
151. Provini F., Antelmi E., Vignatelli L., et al. Association of restless legs syndrome with nocturnal eating: a case-control study. Mov Disord 2009, 24(6):871-877.
152. Najjar M. Zolpidem and amnestic sleep related eating disorder. J Clin Sleep Med 2007, 3(6):637-638.
153. Howell M.J., Schenck C.H., Crow S.J. A review of nighttime eating disorders. Sleep Med Rev 2009, 13(1):23-34.
154. Montagna P. Sleep related eating disorder 2008, MedLink Corporation, Medlin Neurology. San Diego (CA), [Online]. S. Gilman (Ed.).
155. Provini F., Albani F., Vetrugno R., et al. A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. Eur J Neurol 2005, 12(6):432-436.
156. Miyaoka T., Yasukawa R., Tsubouchi K., et al. Successful treatment of nocturnal eating/drinking syndrome with selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 2003, 18(3):175-177.
157. Schenck C.H., Hurwitz T.D., O'Connor K.A., et al. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep 1993, 16(5):457-466.
158. McElroy S.L., Guerdjikova A.I., Martens B., et al. Role of antiepileptic drugs in the management of eating disorders. CNS Drugs 2009, 23(2):139-156.
159. Martinez-Salio A., Soler-Algarra S., Calvo-Garcia I., et al. Rev Neurol 2007, 45(5):276-279. [in Spanish].
160. Winkelman J.W. Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate. Sleep Med 2003, 4(3):243-246.